FDA-cleared profile

RBknee

Radiobotics ApS · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: Measures minimum joint-space width and assesses sclerosis, joint-space narrowing, osteophytes, and radiographic knee osteoarthritis using OARSI and Kellgren-Lawrence criteria.

Clinical role
Fully automated software that measures minimum joint space width on CR or DX images and gives an OARSI/KL-based output to aid medical professionals, without interpreting results; not to be solely relied upon to make or confirm a diagnosis.
Images and patients
X-ray/Radiography · Knee
Key limitation
Keep in mind: Not a substitute for full evaluation or sole basis for diagnosis; trained professionals are required and packet Linux/Docker compatibility is not current deployment assurance.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Measures minimum joint-space width and assesses sclerosis, joint-space narrowing, osteophytes, and radiographic knee osteoarthritis using OARSI and Kellgren-Lawrence criteria.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Knee Input: AP/PA and lateral digital knee radiographs.
  • Who uses it?Intended users: Trained radiologists, orthopedics, physicians, and medical technicians.
  • What does the software produce?Output: Visual overlays and a table with JSW, OARSI, and Kellgren-Lawrence results plus text findings and impression; PACS/DICOM review is supported.
  • What is its most important limitation?Key limitation: Not a substitute for full evaluation or sole basis for diagnosis; trained professionals are required and packet Linux/Docker compatibility is not current deployment assurance.

Clinical takeaway. Clinical role: Measures minimum joint-space width and assesses sclerosis, joint-space narrowing, osteophytes, and radiographic knee osteoarthritis using OARSI and Kellgren-Lawrence criteria.

Evidence takeaway. Evidence from the reviewed source record: OAI dataset with physician ground truth reported task-specific sensitivity and specificity pairs for Kellgren-Lawrence, joint-space narrowing, osteophytosis, and sclerosis; no one generic metric applies.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Measures minimum joint-space width and assesses sclerosis, joint-space narrowing, osteophytes, and radiographic knee osteoarthritis using OARSI and Kellgren-Lawrence criteria.
  • Exact FDA submission
  • Checked 2026-09-15

Clinical-use display mirrors the exact FDA-supported purpose reconciled in this remediation finding.

Workflow role
Fully automated software that measures minimum joint space width on CR or DX images and gives an OARSI/KL-based output to aid medical professionals, without interpreting results; not to be solely relied upon to make or confirm a diagnosis.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "RBknee is a radiological fully automated image processing software device of either computed (CR) or directly digital (DX) images intended to aid medical professionals in the measurement of minimum joint space width;" … "RBknee is not interpreting any results but makes an objective measurement and providing an output based on a well established scale (OARSI/KL).". Read from the exact FDA decision document on 2026-11-14.

Required input
AP/PA and lateral digital knee radiographs.
  • Exact FDA submission
  • Checked 2026-09-15

FDA packet input scope.

Output and clinician action
Visual overlays and a table with JSW, OARSI, and Kellgren-Lawrence results plus text findings and impression; PACS/DICOM review is supported.
  • Exact FDA submission
  • Checked 2026-09-15

FDA packet output scope.

Care setting
Patients whose standing, fixed-flexion knee radiographs are assessed for radiographic knee osteoarthritis (OA); the FDA document does not specify a facility type.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "the presence or absence of radiographic knee OA based on Kellgren-Lawrence grading of standing, fixed-flexion radiographs of the knee." … "information on the presence or absence of radiographic knee osteoarthritis (OA) based on the Kellgren-Lawrence (KL) score.". Read from the exact FDA decision document on 2026-11-14.

Intended users
Trained radiologists, orthopedics, physicians, and medical technicians.
  • Exact FDA submission
  • Checked 2026-09-15

FDA packet intended-user statement.

Limitations
Not a substitute for full evaluation or sole basis for diagnosis; trained professionals are required and packet Linux/Docker compatibility is not current deployment assurance.
  • Exact FDA submission
  • Checked 2026-09-15

Exact FDA limitation boundary.

Evidence summary
OAI dataset with physician ground truth reported task-specific sensitivity and specificity pairs for Kellgren-Lawrence, joint-space narrowing, osteophytosis, and sclerosis; no one generic metric applies.
  • Exact FDA submission
  • Checked 2026-09-15

Submission-reported task-specific results.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
OAI dataset with physician ground truth reported task-specific sensitivity and specificity pairs for Kellgren-Lawrence, joint-space narrowing, osteophytosis, and sclerosis; no one generic metric applies.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-15

Submission-reported task-specific results.

Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Rbknee regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationPopulation described in the exact-submission ACR model card
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K203696
  • Samplen=1403
  • IndependenceIndependence not established

K203696

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K203696. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-09
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: AP/PA and lateral digital knee radiographs.

    Scope: Exact FDA submission. FDA packet input scope.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-15 · FDA K203696: RBknee

  2. Routing

    Source context, not route validation: The exact FDA package describes RBknee taking digital AP/PA radiographs as input, being able to be integrated to a PACS, and providing outputs that can be reviewed in a DICOM viewer. Interface versions and local compatibility require confirmation.

    Scope: Exact FDA submission. Packet wording: "RBknee can be integrated to a PACS and the outputs of RBknee can be reviewed in a DICOM viewer." … "In brief, RBknee takes digital radiographs (AP/PA) as input and as output provides:". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-11-14 · FDA K203696: RBknee

  3. AI processing

    Source context, not route validation: The exact FDA package describes RBknee as operating in a Linux environment and deployable to be compatible with any operating system supporting the third-party software Docker. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "RBknee operates in a Linux environment and can be deployed to be compatible with any operating system supporting the third-party software Docker.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K203696: RBknee

  4. Returned objects

    Source context, not route validation: Visual overlays and a table with JSW, OARSI, and Kellgren-Lawrence results plus text findings and impression; PACS/DICOM review is supported.

    Scope: Exact FDA submission. FDA packet output scope.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-15 · FDA K203696: RBknee

  5. Viewer/worklist/report

    Unresolved route: Visual overlays and a table with JSW, OARSI, and Kellgren-Lawrence results plus text findings and impression; PACS/DICOM review is supported.

    Scope: Exact FDA submission. FDA packet output scope.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-15 · FDA K203696: RBknee

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes RBknee as operating in a Linux environment and deployable to be compatible with any operating system supporting the third-party software Docker. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "RBknee operates in a Linux environment and can be deployed to be compatible with any operating system supporting the third-party software Docker.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The exact FDA package describes RBknee taking digital AP/PA radiographs as input, being able to be integrated to a PACS, and providing outputs that can be reviewed in a DICOM viewer. Interface versions and local compatibility require confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "RBknee can be integrated to a PACS and the outputs of RBknee can be reviewed in a DICOM viewer." … "In brief, RBknee takes digital radiographs (AP/PA) as input and as output provides:". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Supported acquisition environment

Scanner manufacturers: All

exact submission · checked 2026-09-01

Confirm currently supported software versions, protocols, and site-specific acquisition configurations.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for RBknee; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-09
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K203696
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-15

FDA CR/DX standing fixed-flexion knee-radiograph scope.

Anatomy
Knee
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-15

Exact FDA knee scope.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2021-08-27
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission

    No public price or quote for the exact K203696 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-09 - Exact FDA submission

    Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-09 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K203696: RBknee

    U.S. Food and Drug Administration - Published 2021-08-27 - Accessed 2026-09-09

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, purpose, intendedUsers, input, output, limitations, evidenceSummary, deployment, integration

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Rbknee model card (K203696)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, output, limitations, evidenceSummary, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K203696

    U.S. Food and Drug Administration - Accessed 2026-09-09

    Scope: postmarketSafety

Research history

  1. K203696 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K202487

HealthJOINT

Zebra Medical Vision Ltd.

Authorized purpose: Uses AI to reconstruct bones in three dimensions from two-dimensional radiographs for preoperative knee orthopedic planning.

Modality
X-ray/Radiography
Anatomy
Knee
Decision
2020-12-04
FDA-cleared K250914

MediAI-BA

Crescom Co., Ltd.

Authorized purpose: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.

Modality
X-ray/Radiography
Anatomy
Left hand and wrist; skeletal maturity/bone age
Decision
2025-12-18
FDA-cleared K252086

DTX Studio Assist

Nobel Biocare C/O Medicim NV

Authorized purpose: Analyzes two-dimensional bitewing and periapical radiographs of permanent teeth in patients aged 15 and older to identify and localize caries, calculus, periapical radiolucency, root canal filling deficiency, discrepancy at an existing restoration margin, and bone loss; also supports alveolar bone-level measurement and restoration/dental-anatomy segmentation as an adjunct to dentist review.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-17
FDA-cleared K250264

SugarBug (1.x)

Bench7, Inc.

Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-07

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history